Lysozyme is an important antimicrobial agent with promising future in replacing antibiotics in 25 livestok production.The aim of current study was to determine variations in sow's gut microbiota, 26 serum immunity and breast milk metabolite profile mediated by lysozyme 27 supplementation.Thirty-six pregnant sows were assigned to a control group without 28 supplementation and two treatments with 0.5 g/kg and 1.0 g/kg lysozyme provided in formula feed 29 for 21days. Microbiota analysis based on 16s RNA high-throughput sequencing and untargeted 30 liquid chromatography tandem mass spectrometry were applied and combined in analysis. Serum 31 biochemical indicators and immunoglobulins were also determined.Sows received 1.0kg/t 32 lyszoyme treatment shown significant redution in microbial diversity. Spirochaetes, Euryarchaeota 33
lysozyme alters sow's gut microbiota and health each sample was added to 400 μl pre-cooled methanol/acetonitrile (1:1, v/v), vortex mixed, 193 stood at -20°C for 60 min, centrifuged at 14,000 g for 20 min at 4°C, take the supernatant and 194 vacuum dried. For mass spectrometry, 100 μl of acetonitrile aqueous solution (acetonitrile:water = 195 1:1, v/v) was reconstituted, vortexed, centrifuged at 14,000 g for 5 min at 4°C, and the supernatant 196 was taken for further analysis on LC-MS/MS platform (Bioprofile Co. Ltd, Shanghai, China). 197
Each sample was tested by positive ion and negative ion mode using electrospray ionization (ESI). and rules used in our previous research [44] . 205
206

Statistical Analysis 207
All statistical analyses were performed using SPSS 25.0 software (SPSS Inc., Chicago, IL). 208
Alpha and beta diversity were analyzed with QIIME (v1.7.0) and displayed with R software 209 (v3.5.1) and details can be found in the legends of the corresponding figures and tables. The 210 differences among groups were compared using one-way ANOVA and Tukey-Kramer multiple 211 comparison tests. P values < 0.05 were used to indicate statistical significance, whereas 0.05 ≤ P 212 values < 0.1 were considered to be trending toward significance. 213 214 lysozyme alters sow's gut microbiota and health
Results 215
Dietary lysozyme supplementation altered the diversity and composition of sow's gut 216 microbiota 217
Microbial diversity, evidenced by the Shannon index, showed a significant reduction in the 1.0 218 kg/t group compared with the lysozyme-treated group (p = 0.0014, Figure 1A ) and no remarkable 219 differences were found in indicators of microbial richness (ACE and Chao1, Sup Table 1 ). The 220 principal coordinate analysis (PCoA) based on Bray-Curtis dissimilarity revealed that microbiota 221 showed obvious segregation from the control group to lysozyme-treated groups ( Figure 1B) . In 222 addition, non-metric multidimensional scaling (NMDS) plots of β-diversity weighted unifrac 223 ( Figure 1C ) also confirmed the differences between control and lysozyme-treated groups (all P < 224 0.05 by Anosim analysis and multi-response permutation procedure (MRPP)). Furthermore, an 225 unweighted pair-group method with arithmetic mean (UPGMA) analysis based on weighted 226 unifrac distances were applied and the phylogeny showed the relationships of all observed 227 samples. The phylogeny revealed that Firmicutes, Bacteroidetes, Proteobacteria, and 228
Fibrobacteres are the dominant bacteria in sow's gut microbiome (Sup Figure1) . 229
Further, variations in the microbial composition of all groups were explored. LEfSe analysis of 230 the bacterial community was used to filter the significantly different OTUs among groups and the 231 results showed that there exist dramatic differences in microbial composition between the 1.0 g/kg 232 group and the control group ( Figure 1D) . Spirochaetes, Euryarchaeota, and Actinobacteria 233 significantly increased while Firmicutes showed a remarkable reduction in the 1.0 kg/t treated 234 group compared with the control. Proteobacteria also showed lower richness in the 1.0 kg/t group 235 (p = 0.077, Table 1 ). The heat map (according to the top 35 most different genera) shows the 236 lysozyme alters sow's gut microbiota and health taxonomic distributions among each group ( Figure 1E ). Specifically, Escherichia coli was 237 dramatically reduced in both the 0.5 kg/t and the 1.0 kg/t lysozyme-treated groups. Furthermore, 238
Lactobacillus amylovorus showed a significant increase in the 0.5 kg/t group ( Figure 1F) . 239
To further determine the relationships among different microbes in the control and the 1.0 240 kg/t group, network analysis of gut microbiome was determined by calculating Spearman's 241 correlation coefficients among all genera. The results revealed that lysozyme supplementation 242 with 1.0 kg/t rebuilt interactions among different genera ( Figure 1H functions of sow's gut microbiota showed obvious segregation from the control group to 256 lysozyme-treated groups ( Figure 2B ). Furthermore, 80 pathways were found to significantly differ 257 among groups at KEGG level 3, including those associated with cellular processes, environmental 258 lysozyme alters sow's gut microbiota and health factors, genetic information processing, organismic systems, metabolism, and human diseases 259 (Table S2 ). LEfSe analysis of the KEGG annotation results was used to filter the significantly 260 differed pathways among groups and results showed that there exist dramatic differences in 261 microbial composition between the 1.0 g/kg group and the control group ( Figure 1D ), which is in 262 line with variations in microbial structure. In the present study, metabolism related pathways at 263 KEGG Level 3 were specifically concerned and filtered. The heat map (according to the most 264 different metabolism related pathways) showed the specific functional pathway distribution 265 among each group ( Figure 2D ). Moreover, pyrimidine metabolism, purine metabolism and amino 266 acid related enzymes were significantly upregulated in the 1.0 kg/t lysozyme-treated group. 267
268
Lysozyme treatment significantly reduced the richness of Gram positive bacteria 269
To determine the reported impact of lysozyme on gram-positive bacteria, organism-level 270 coverage of functional pathways and biologically interpretable phenotypes were predicted via 271
BugBase, an algorithm that predicts organism-level coverage of functional pathways, as well as 272 biologically interpretable phenotypes, such as oxygen tolerance, gram staining and pathogenic 273 potential, within complex microbiomes using either whole-genome shotgun or marker gene 274 sequencing data. Results demonstrated that the richness of gram-positive bacteria were 275 significantly down-regulated by lysozyme treatments, while gram-negative bacteria showed a 276 significant increase ( Figures 3D and 3E ). Mobile genetic elements and oxidative stress tolerance 277 of gut microbiota were reduced by increased lysozyme level ( Figures 3F and 3I) . Otherwise, 278 lysozyme supplementation significantly increased biofilm formation in the lysozyme-treated 279 groups ( Figure 3H) . 280
Lysozyme mediated changes in serum biochemical markers and their correlations with gut 282 microbiota 283
To identify the impact of lysozyme on sows' immunity, serum biochemical indices and 284 immunoglobulins were determined. Results showed that serum aspartate transaminase (AST) 285 levels were significantly upregulated by lysozyme treatment and as a result, AST/ALT (alanine 286 transaminase) ratios rose in the lysozyme-treated group (p = 0.080) ( Table 2 ). Dietary lysozyme 287 supplementation had no significant impact on serum metabolite profiles (e.g., HDL-c, LDL-c, TG, 288 and BUN). For immunoglobulins, serum IgM levels were significantly higher in the 1.0 kg/t group 289 compared with the control, while IgA levels were significantly lower in the 1.0 kg/t group ( Figure  290 
4A and C). 291
To further explore the relationship between immunity and the altered gut microbiome driven by 292 lysozyme treatment, Spearman's correlation coefficients between serum biochemical makers and 293 immunoglobulins and major genera were calculated and visualized with heatmaps. Twelve genera, 294
including Prevotella, Ruminococcaceae UGG, and Bacteroides showed significant correlations 295 with IgA ( Figure 4D ). Ruminiclostridium 9 showed a significant positive relation with IgM. 296
Methanobrevibacter showed a significantly negative relationship with AST, while Lactobacillus 297 showed a significant positive correlation ( Figure 4D) . between lysozyme-treated groups and the control. The heat map (according to the most different 307 metabolites) showed specific metabolite distributions within each group ( Figure 5D ). Twenty 308 metabolic makers were identified by PLS-DA including Uridine 5ʹ-diphosphate (UDP), 309 UDP-D-glucuronate, acamprosate, and triethanolamine ( Figure 5E ). In addition, ten metabolites 310 were filtered by sPLS-DA including succinate, L-glutamine, and UDP-D-glucuronate (Sup Figure  311 2). Given this, metabolites significantly differed among groups were filtered and combined via 312 both PLS-DA and sPLS-DA (Table 3) . Moreover, significant differences metabolites between the 313 1.0 kg/t and the control groups were also filtered via PLS-DA (Sup Figure3) and metabolic makers 314 were obtained (Sup Table. 
4). 315
To explore the biological functions of these metabolic makers, metabolite-set enrichment 316 analysis was performed via MetaboAnalyst v4.0 ( Figure 5G ). Pathway topology analysis using 317 relative centrality revealed nine significantly different (P < 0.05) enriched pathways ( Figure 5F ), 318 including alanine, aspartate, and glutamate metabolism, pyrimidine metabolism, arginine and 319 proline metabolism, galactose metabolism, ascorbate and aldarate metabolism, amino sugar and 320 nucleotide sugar metabolism, starch and sucrose metabolism, purine metabolism, and the citrate 321 cycle (Table 4) . 322
lysozyme supplementation 325
To further investigate the correlation between breast milk metabolic indicators and the altered gut 326 microbiome driven by lysozyme treatment, Spearman's correlation coefficients between 327 significantly different metabolites and major genera were also calculated and visualized with heat 328 map ( Figure 6A ). For instance, L-Glutamine showed significant positive correlations with 329
Lactobacillus, Ruminococcus 1 and Lachnospiraceae MK4A136 group. L-Arginine showed 330 significant negative correlations with Sphaerochaeta, Prevotella 1, Pseudobutyrivibrio, and 331 Prevotella 9. Moreover, lysozyme-supplementation mediated associations among breast milk 332 composition, serum immunity, and gut microbiota were also summarized and bacteria showed 333 significant impact on both serum biomarkers and breast milk metabolic makers were filtered 334 Lysozyme driven metabolic function in microbial communities were investigated in this 363 research. The results show that pyrimidine metabolism, purine metabolism, and amino acid related 364 enzymes were significantly upregulated in the 1.0 kg/t lysozyme-treated group. Broadly speaking, 365 lysozyme promoted the shift to greater amino acid and nucleotide metabolism in microbes ( Figure  366 2). In this research, the richness of gram-positive bacteria was significantly down-regulated by 367 lysozyme treatments. Our findings confirmed that lysozyme has a robust antimicrobial activity 368 lysozyme alters sow's gut microbiota and health against gram-positive bacteria, and to a much lesser degree, against gram-negative bacteria [18] . 369
Lysozyme supplementation also significantly increased biofilm formation in the lysozyme-treated 370 groups ( Figure 3H ). The formation of microbial community biofilms is closely linked to drug 371 resistance and pathogenesis [51, 52] . Further studies may focus on the mechanisms of lysozyme 372 mediated microbial metabolism. In summary, lysozyme supplementation could effectively 373 improve the composition, metabolic functions, and phenotypes of sow's gut microbiota. 374
Lysozyme is also an important modulator in non-specific immunity and plays a crucial role in 375 preventing intestinal inflammation [5, 10, 22]. SIgA is predominantly recognized for its role in 376 host defense of the mucosa, where it prevents the invasion of pathogens by neutralization [53] . 377
Lower serum IgA indicates a lower risk of allergy in the postnatal period, which differs from 378 mucosal SIgA [54] . IgM is an important immunoglobulin that functions in the anti-inflammatory 379 response and increased IgM indicating a better immune status [55] . In this study, sow's serum IgA 380 levels were significantly reduced by increased lysozyme levels. Meanwhile, serum IgM was 381 significantly higher in the 1.0 g/kg group compared with the control group. What is more, serum 382 aspartate transaminase (AST) levels were also significantly upregulated by lysozyme treatment. 383 AST, a liver-specific enzyme that is released into serum following acute liver injury, is used in 384 experimental organ preservation studies as a measure of liver ischemia-reperfusion injury [56] . 385
Hence, reduced serum AST levels induced by lysozyme treatments indicate improved overall 386 health. Lysozyme supplementation could benefit sows with better immune status via up-regulating 387 serum AST and IgM levels. significantly upregulated the beneficial metabolites in sow's milk, which may exert a long-term 400 impact on the development of offspring. Further, our findings of pathway enrichment and 401 topology analysis of these metabolites revealed nine significantly different (P < 0.05) enriched 402 pathways ( Figure 5F ) including alanine, aspartate, and glutamate metabolism and pyrimidine 403 metabolism, arginine, and proline metabolism, which further supports the conclusions noted 404
above. 405
Gut microbiota play multiple roles in animal growth and health, including energy extraction 406 from food, gut barrier function and immune system maturation, and growth performance [30, 31] . 407
For serum immunity makers, 12 genera including Prevotella, Ruminococcaceae UGG, and 408
Bacteroides showed significant correlations with IgA ( Figure 4D ). Ruminiclostridium 9 showed a 409 significant positive relationship with IgM. Methanobrevibacter showed a significant negative 410 relationship with AST, while Lactobacillus showed significantly positive correlation ( Figure 4D) . 411
Breast milk metabolites, such as L-glutamine, showed a significant positive correlation with 412 lysozyme alters sow's gut microbiota and health Lactobacillus, Ruminococcus 1, Lachnospiraceae, and the MK4A136 group; and L-arginine 413 showed significant negative correlations with Sphaerochaeta, Prevotella 1, Pseudobutyrivibrio 414 and Prevotella 9. These findings confirmed that gut microbiota plays an important role in 415 lysozyme-mediated changes in serum immunity and breast milk composition. Genera that exerted 416 a significant effect on both serum immune indices and milk metabolites were filtered, and a 417 possible regulation network is shown in Figure 6B . Based previous reports, Lactobacillus and 418
Prevotella may play a key role in lysozyme mediated host-microbial interactions [3, 46, 50] . 419
The application of antibiotics in feeds at subtherapeutic levels could improve performance 420
and overall health and is used extensively throughout the swine industry 
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